纳米Fe3O4-TiO2靶向光动力疗法对肝癌细胞的杀伤效应

光动力疗法(PDT)作为一种迅速发展的传统替代疗法,在抗癌治疗中显示出巨大的潜力.为增强靶向性和提高光催化杀伤效率,本研究设计了一种新型光敏剂Fe₃O₄-TiO₂磁性纳米粒.在不同外磁场下,考察其在可见光和紫外光激发下对肝癌细胞的杀伤效应.同时利用流式细胞术检测纳米Fe₃O₄-TiO₂对肝癌细胞凋亡率、细胞周期和线粒体膜电位的影响.根据纳米Fe₃O₄-TiO₂和肝癌细胞的作用方式探讨其抗癌机制.结果表明,可见光激发纳米Fe₃O₄-TiO₂可以杀伤癌细胞,且其杀伤效率与紫外光激发下无明显差别.此外,Fe₃O₄-TiO₂比TiO₂具有更高的细胞摄取率,从而使其具有更高的选择性和光催化杀伤效率.其作用机制是光催化纳米Fe₃O₄-TiO₂产生活性氧ROS抑制癌细胞,然后通过阻滞细胞周期G₀/G₁期,降低线粒体膜电位,线粒体去极化,最终诱导细胞凋亡.     

纳米TiO2-免疫-电生孔复合技术光催化氧化杀伤LoVo肠癌细胞的机理

纳米TiO2光催化氧化-免疫-电生孔复合技术能够在低的纳米TiO2浓度条件下(3.12 μg·mL-1)高效选择性地杀伤LoVo肠癌细胞. 在光强为4 mW·cm-2的紫外光(波长253.7 nm)照射下, 30 min内可全部杀死癌细胞. 利用共聚焦荧光显微镜、透射电镜(TEM)和单细胞凝胶电泳的方法研究了其作用过程. 结果表明, 经抗体修饰的纳米TiO2微粒能自动吸附在癌细胞的细胞膜上, 在电脉冲作用下纳米TiO2可进入细胞内部, 并主要集中在细胞核区域. 在紫外光的照射下, 基于纳米TiO2的光催化氧化作用, 造成细胞内一些细胞器、核膜和核中DNA的损伤, 使细胞坏死. 由于是在细胞内部产生光催化氧化作用, 显著提高了杀伤LoVo肠癌细胞的能力.     

Au改性TiO2纳米复合物对人结肠癌细胞的光催化杀伤作用

提出了通过TiO₂表面修饰纳米Au的方法来提高纳米TiO₂光催化杀伤癌细胞的效率. 采用化学还原法合成了Au改性的TiO₂ (Au/TiO₂)纳米复合物, 并研究了不同掺杂量(1 wt%, 2 wt%, 4 wt%)的Au/TiO₂对人结肠癌LoVo细胞的光催化杀伤效应. 结果显示, Au的掺杂大大地提高了TiO₂纳米粒子光催化杀伤结肠癌LoVo细胞的效率, 而且Au掺杂量的高低影响Au/TiO₂光催化杀伤癌细胞的效率, 掺金量为2%的Au/TiO₂对结肠癌LoVo细胞具有最高的光催化杀伤效率. 在光强为1.8 mW/cm²的紫外灯(λ_max＝365 nm)下光照110 min, 50 μg/mL掺金量为2%的Au/TiO₂能够杀死所有的癌细胞, 而同样浓度的TiO₂只能杀死70%的癌细胞.     

纳米TiO2-免疫-电生孔复合技术光催化氧化杀伤LoVo肠癌细胞的机理

纳米TiO2光催化氧化·免疫.电生孔复合技术能够在低的纳米TiO2浓度条件下(3.12 μg·mL-1)高效选择性地杀伤LoVo肠癌细胞.在光强为4 mW·cm-2的紫外光(波长253.7 nm)照射下,30 min内可全部杀死癌细胞.利用共聚焦荧光显微镜、透射电镜(TEM)和单细胞凝胶电泳的方法研究了其作用过程.结果表明,经抗体修饰的纳米TiO2微粒能自动吸附在癌细胞的细胞膜上,在电脉冲作用下纳米TiO2可进入细胞内部,并主要集中在细胞核区域.在紫外光的照射下,基于纳米TiO2的光催化氧化作用,造成细胞内一些细胞器、核膜和核中DNA的损伤,使细胞坏死.由于是在细胞内部产生光催化氧化作用,显著提高了杀伤LoVo肠癌细胞的能力.     

Fe-Ni/TiO2纳米管阵列电极的制备、表征及光电催化还原五氯酚活性

采用阳极氧化法和浸渍电沉积联用法制备了不同负载量的Fe-Ni/TiO2纳米管阵列电极. 通过扫描电子显微镜(SEM)、 X射线光电子能谱(XPS)和电化学测量等手段对样品的微观形貌、 晶体结构和光电响应等特性进行分析. 考察了在0.6 V偏压下, 所制备的电极对五氯酚的光电催化还原性能. 结果表明, 适量的Fe和Ni纳米颗粒的负载, 降低了TiO2纳米管阵列光生电子-空穴对的复合几率; 浸渍电沉积5次的Fe-Ni/TiO2纳米管阵列电极光电催化还原降解五氯酚的效率为91.35%, 明显高于TiO2纳米管阵列电极.     

纳米Fe_3O_4-TiO_2靶向光动力疗法对肝癌细胞的杀伤效应（英文）

光动力疗法(PDT)作为一种迅速发展的传统替代疗法,在抗癌治疗中显示出巨大的潜力。为增强靶向性和提高光催化杀伤效率,本研究设计了一种新型光敏剂Fe_3O_4-Ti O_2磁性纳米粒。在不同外磁场下,考察其在可见光和紫外光激发下对肝癌细胞的杀伤效应。同时利用流式细胞术检测纳米Fe_3O_4-Ti O_2对肝癌细胞凋亡率、细胞周期和线粒体膜电位的影响。根据纳米Fe_3O_4-Ti O_2和肝癌细胞的作用方式探讨其抗癌机制。结果表明,可见光激发纳米Fe_3O_4-Ti O_2可以杀伤癌细胞,且其杀伤效率与紫外光激发下无明显差别。此外,Fe_3O_4-Ti O_2比Ti O_2具有更高的细胞摄取率,从而使其具有更高的选择性和光催化杀伤效率。其作用机制是光催化纳米Fe_3O_4-Ti O_2产生活性氧ROS抑制癌细胞,然后通过阻滞细胞周期G_0/G_1期,降低线粒体膜电位,线粒体去极化,最终诱导细胞凋亡。     

紫外光照处理对TiO2膜光伏性能的影响

近年来人们利用纳米晶TiO2电极取代普通的TiO2电极[1],使其太阳能电池的光电转换效率得到很大提高.纳米晶TiO2电极具有大量表面态,在化学上表现为Ti3+或Ti—OH,对于光生电荷的分离过程和迁移过程有重要影响.这些表面化学结构的变化可能会导致TiO2的光伏性能的变化.1997年Fujishima等[2]用紫外光照射TiO2膜使它具有超亲水的性质,结构分析表明,超亲水的原因在于光照使TiO2膜的表面形成Ti—OH[3].因此,在光照处理的同时可能会导致TiO2的光伏性的变化.本文对紫外光照处理TiO2膜的光伏性能进行了研究,并结合光诱导TiO2的亲水性变化对光伏性能变化的原因进行了讨论.     

新型2,6-二取代嘌呤衍生物的合成及其抗肿瘤活性

以2,6-二氯嘌呤为原料,对其2-位和6-位进行结构修饰,合成了8个新型2,6-二胺嘌呤类衍生物(3a~3h),其结构经¹H NMR, IR和MS（ESI）表征。采用MTT法研究了3a~3h对人胃癌SGC-7901细胞的体外抗肿瘤活性。结果表明: 3a, 3b, 3c, 3g具有良好的抗肿瘤活性,其中3c（IC₅₀ 65.01 μmol·L^-1）对人胃癌细胞SGC-7901的抑制作用最强。     

掺杂Cu的TiO2纳米粒子的制备、表征及其光催化活性

采用Sol-gel法制备了纯的和掺杂不同量Cu的TiO2纳米粒子,并用TG-DTA,XRD,XPS,UV-Vis和荧光光谱对样品进行了表征,考察焙烧温度和Cu含量对TiO2纳米粒子的性质及光催化活性的影响,初步探讨了Cu的掺杂对TiO2相变的作用机制及样品荧光光谱与光催化活性的关系.结果表明,Cu2+的掺杂对TiO2的相变有很大的促进作用,并使其光谱响应范围向可见光区拓展.Cu的掺杂未引起新的荧光现象,但适量Cu的掺杂能够降低TiO2纳米粒子的荧光强度.此外,在光催化降解苯酚的实验中,于500℃处理的掺杂Cu的TiO2纳米粒子的光催化活性较高,与表征结果一致.而掺杂不同量Cu的TiO2的光催化活性顺序与样品荧光光谱强度的顺序相反,即荧光光谱强度越低,其光催化活性越高.     

ZnO和TiO2纳米粒子的光致发光性能及其与光催化活性的关系

采用沉淀法和溶胶-凝胶法制备了ZnO和TiO2及掺Zn2+的TiO2纳米粒子,用XRD和荧光光谱(FS)等手段对样品进行了表征,重点探讨了样品光致发光机制及与光催化活性的关系.结果表明,ZnO和TiO2样品在大于带隙能的光激发下均表现出明显的FS信号,热处理温度升高,FS信号强度下降,并且二者的FS信号类似,这可能与二者具有类似的电子能带结构有关,同时也说明FS信号主要源于表面氧空位以及吸附氧物种等引起的激子或表面态能级.掺杂Zn2+使TiO2纳米粒子FS信号增强,这主要与表面氧空位和缺陷等量增加有关;此外,在光催化氧化苯酚实验中,样品光催化活性与其FS信号强度顺序一致,即FS信号越强,活性越高.这是由于在光致发光过程中,FS信号主要源于表面氧空位,而在光催化反应中,表面氧空位有利于氧化反应进行.     

基于双向浓度梯度的微流控芯片系统对 肿瘤细胞侵袭能力的多重分析

利用微流控芯片易于模拟体内生理环境、 流体控制精确及易于集成等优势, 将基于扩散原理的浓度梯度形成结构与经典的圣诞树形浓度梯度发生器相集成, 建立了在垂直和水平方向上形成连续、 双向浓度梯度的微流控芯片系统, 采用该系统对不同类型细胞(HEK-293, MCF-7, SGC-7901)的侵袭力进行了定量分析; 通过在垂直方向上施加血清浓度梯度, 在水平方向上施加抗肿瘤药物十字孢碱浓度梯度, 分析了在连续药物浓度作用下的人胃癌SGC-7901细胞侵袭能力被抑制的情况, 同时观察并定量评价了伴随细胞侵袭力变化过程中细胞增殖能力受抑制的情况. 研究结果表明, 该系统可形成稳定的双向物质浓度梯度; 在血清浓度梯度存在情况下, 伴随十字孢碱浓度梯度的升高, 肿瘤细胞侵袭(P<0.0001)和增殖能力(P<0.001)均呈现浓度依赖性的连续降低. 建立的双向浓度梯度微流控芯片系统可用于评价复杂环境对细胞的多重影响, 也为研究细胞间相互作用、 多种药物联用及药物筛选等提供了良好的研究平台.     

Apoptosis of Human Gastric Carcinoma SGC-7901 Induced by Deoxycholic Acid via the Mitochondrial-Dependent Pathway

The study aimed to evaluate the effects of deoxycholic acid (DCA) on human gastric carcinoma cell lines and to explore its mechanisms. In the present study, effects of DCA on SGC-7901 cell growth, cell cycle, and apoptosis were investigated by MTT assay, inverted microscopy, fluorescence microscopy, PI single- and FITC/PI double-staining flow cytometry, and western blotting. The study have revealed that DCA significantly inhibited the growth of SGC-7901 cells in a dose- and time-dependent manner and arrested cell cycle at G0/G1 phase. SGC-7901 cells showed typical apoptotic morphological changes after treated with DCA for 48 h. The intensity of typical apoptosis pattern- “ladders” formed by DNA in fragments of multiples of 200 base pairs was also observed. Apoptosis of SGC-7901 cells induced by DCA were associated with collapse of the mitochondrial membrane potential. DCA treatment could also increase the ratio of Bax to Bcl-2 in SGC-7901 cells. Meanwhile, the expression of p53, cyclinD1, and c-Myc were changed after DCA treatment. These results suggest that DCA induces apoptosis of gastric carcinoma cells through an intrinsic mitochondrial-dependent pathway, and the increase in the Bax/Bcl-2 ratio and collapse of the mitochondrial membrane potential may play important roles in DCA-induced apoptosis of gastric carcinoma cells.     

Photokilling cancer cells using highly cell-specific antibody-TiO(2) bioconjugates and electroporation

In this paper, it was reported for the first time that the combination of the electroporation and the conjugation of the TiO(2) nanoparticles with the monoclonal antibody could improve the photokilling selectivity and efficiency of photoexcited TiO(2) on cancer cells in the photodynamic therapy(PDT) because the conjugation of the TiO(2) nanoparticles with monoclonal antibodies could increase the photokilling selectivity of TiO(2) nanoparticles to cancer cells and the electroporation could accelerate the delivery speed of the TiO(2) nanoparticles to cancer cells. It was observed that using this combination method, 100% human LoVo cancer cells were photokilled within 90 min, while only 39% of the normal cells were killed under the irradiation of the ultraviolet (UV) light (365 nm). Furthermore, the combination method may be used to photokill various kinds of caner cells only if the antibody conjugated on the TiO(2) nanoparticles is changed.     

Etoposide Induces Mitochondria-Associated Apoptotic Cell Death in Human Gastric Carcinoma Cells

Recent observations indicate that the resistance of apoptosis is an important process of tumor metastasis and metastases are the cause of 90% of human cancer death. Etoposide, a semisynthetic derivative of the podophyllotoxins, is a clinically used anti-cancer reagent, but the effects of it on metastatic gastric carcinoma cells are totally unknown. In this study, etoposide induced apoptotic cell death in human gastric adenocarcinoma cell line SGC-7901, derived from metastatic lymph nodes, as evidenced by the analysis of DNA fragmentation, apoptotic body formation, caspase activation, and apoptosis specific changes in cell morphology is demonstrated. The depolarization of mitochondrial membrane and the release of cytochrome c were most early events in etoposide treated SGC-7901 cells, and were followed by caspase-3 activation and PARP cleavage. Caspase-8 activation was not detected under the same condition. Thus, it was proposed that etoposide induces caspase-associated apoptotic cell death in human metastatic gastric carcinoma, which is initiated by mitochondrial cytochrome c release.     

Inhibitory Effect of Anti-HER-2 Anti-CD3 Bi-specific Antibody on the Growth of Gastric Carcinoma

Introduction Gastriccancerisoneofthemostcommonlyen counteredmalignantdiseasesworldwide,especiallyin AsiaandAfrica[1].Thecombinationofoperation,chemotherapyandradiotherapyisusedfortreatinggas triccarcinoma.However,the5yearsurvivalrateof patientsofgastricca…     

6-氯-4-哌嗪基喹唑啉缩氨基硫脲类化合物的合成及体外抗肿瘤活性

以5-氯-2-氨基苯甲酸和甲酰胺为起始原料,经环化、氯化、取代和缩合反应,合成了3个未见文献报道的含哌嗪的喹唑啉衍生物5a~5c。 其结构用1H NMR、13C NMR、ESI-MS及IR测试技术进行了表征。 采用MTT法测试了化合物5a~5c对人胃癌SGC-7901、人口腔表皮样癌KB和人纤维肉瘤HT-1080的体外抗肿瘤活性。 结果表明,化合物5a~5c对人胃癌SGC-7901和人纤维肉瘤HT-1080有弱的抑制活性,而对人口腔表皮样癌KB无明显抑制活性。     

二肽类膦酸酯衍生物的合成与抗肿瘤活性

为了寻找抗肿瘤活性化合物,以前期研究的含一个氨基酸结构单元的膦酸酯衍生物为基础,设计合成了15个二肽类膦酸酯衍生物(Ⅲa-Ⅲo)。采用溴化噻唑蓝四氮唑(MTT)法进行体外抗肿瘤活性测试。结果表明:该类化合物对人肺癌细胞(A-549)、人胃癌细胞(SGC-7901)和人食管癌细胞(EC-109)有潜在增殖抑制作用。其中,化合物Ⅲf对A-549和EC-109的半数抑制浓度(IC 50)分别为(6.9±1.2)和(6.3±1.0)μmol/L,化合物Ⅲn对SGC-7901和EC-109的IC 50分别为(6.7±1.0)和(6.1±1.0)μmol/L,与对照药顺铂接近。     

Synthesis,characterization and in vitro antitumor behavior of a vanadium(V) complex with 4′-(3-methoxyphenyl)-2,2′:6′2″-terpyridine

A dioxovanadium(V) complex, [VO₂(moptpy)](ClO₄) (1, moptpy = 4′-(3-methoxyphenyl)2,2′:6′2″-terpyridine), was synthesized and characterized by elemental analysis, ESI-MS, UV–vis, IR, and ¹H, ¹³C, and ⁵¹V NMR. The cytotoxicity in vitro of 1 was evaluated against cancer cell lines HepG-2 (hepatocellular carcinoma), SGC-7901 (gastric carcinoma), SiHa (cervical cancer), BEL-7402 (hepatocellular), and rat PC-12 (pheochromocytoma) by the MTT method. The results demonstrated that 1 exhibits superior anticancer activity in vitro with much lower values of 50% inhibitive concentration (IC₅₀) against the selected cell lines than cisplatin, and 1 shows the highest cytotoxic activity toward SGC-7901 cells (IC₅₀ = 1.3 ± 0.1 μM) among the selected cell lines. A series of cellular morphological and staining experiments were carried out, and the results indicated that 1 can effectively induce apoptosis of SGC-7901 cells through a ROS-mediated mitochondrial dysfunction pathway. In addition, cellular incorporation and cell cycle analysis were also performed, and it was concluded from the experimental observations that 1 can efficiently enter into the cell nuclei, and the complex inhibits cell growth in SGC-7901 cell at G0/G1 phase.     

Synthesis, characterization and anti proliferative effect of [Au(en)2]Cl3 and [Au(N-propyl-en)2]Cl3 on human cancer cell lines

Two Au(III) complexes of the type [Au(en)2]Cl3 (2a) and [Au(N-pr-en)2]Cl3 (3a) were synthesized by reacting Auric acid (HAuCl(4)·3H2O) with 2 equiv. ethylenediamine (en) or N-alkyl substituted ethylenediamine ligands. This metallodrug was characterized by various analytical and spectroscopic techniques such as elemental analysis, UV-Vis, Far-IR, 1H NMR and solution 13C as well as solid 13C and 15N NMR. Potentiality of [Au(en)2]Cl3 and [Au(N-pr-en)2]Cl3 as an anti-cancer agent were investigated by measuring some relevant physicochemical and biochemical properties such as stability of Au-N bonds by vibrational stretching from Far IR as well as cytotoxicity and stomach cancer cell inhibiting effect, respectively. The solid-state 15N NMR chemical shift shows that the ligand is strongly bound to gold(III) centre via N atoms. The computational study of 2a shows that the gold coordination sphere adopts distorted square planar geometry with bidentate ethylenediamine ligands acting as a tetradentate chelate. While stable in the solution state, the in vitro biological studies performed with these compounds 2a in solution showed higher activity towards the inhibitory effects of the human cancer cell lines such as prostate cancer (PC-3) and gastric carcinoma (SGC-7901) than that of the N-substituted gold(III) complex (3a). Cytotoxicity of the new compounds has also been estimated in PC-3 and SGC-7901 cells.     

Two novel alkaloids from the stem of Saprosma hainanense and their cytotoxic activities in vitro

Two novel alkaloids, saprosmine A (1) and saprosmine B (2), were isolated from the stem of Saprosma hainanense MERR., along with five known alkaloids: marcanine A (3); cleistopholine (4); 4-methoxycarbonyl-5,10-benzogquinolinequinone (5); liriodenine (6); and quinoline (7). The chemical structures were established on the basis of extensive spectroscopic (IR, 1D-NMR, 2D-NMR, MS) data analysis and by comparison with spectroscopic data reported in the literature. Compounds 1 to 6 were evaluated for in vitro cytotoxic activities against the SPC-A-1 (human lung cancer), BEL-7402 (human hepatocellular carcinoma), SGC-7901 (human gastric cancer), and K-562 (human myelogenous leukaemia) cancer cell lines. Compounds 1 and 2 exhibited weak cytotoxic activities against K-562 cells. Compounds 3 and 5 showed cytotoxic activities against all four cancer cell lines.